Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Zentalis Pharmaceuticals, Llc (ZNTL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 84,924,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Co. is developing a pipeline of product candidates with an initial focus on validated oncology targets. Co. has two primary product candidates: ZN-c3, an inhibitor of Wee1, a protein tyrosine kinase, and ZN-c5, an oral selective estrogen receptor degrader. Co.'s other clinical product candidates include ZN-d5, a selective inhibitor of B-cell lymphoma 2 and ZN-e4, an irreversible inhibitor of mutant epidermal growth factor receptor.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 22,000 22,000
Total Buy Value $0 $0 $219,391 $219,391
Total People Bought 0 0 2 2
Total Buy Transactions 0 0 2 2
Total Shares Sold 3,356 32,218 167,164 362,029
Total Sell Value $42,353 $375,045 $4,063,616 $8,774,551
Total People Sold 1 5 8 8
Total Sell Transactions 1 7 13 35
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 237
  Page 10 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Gallagher Cam Director   –       •      –    2020-04-07 4 A $0.00 $0 D/D 73,478 489,143     -
   Johnson David Michael Director   –       •      –    2020-04-07 4 A $0.00 $0 D/D 51,587 110,648     -
   Shabet Rose Sharon 10% Owner   –       –       •   2020-04-07 4 B $18.00 $13,050,000 I/I 725,000 4,443,284 1.5     -
   Recurium Equity, Llc 10% Owner   –       –       •   2020-04-03 3 IO $0.00 $0 D/D 0 4,162,930     -
   Matrix Capital Management Company, Lp Director   –       •       •   2020-04-03 3 IO $0.00 $0 I/I 0 3,821,739     -
   Bunker Kevin D. Chief Operating OfficerOfficer   •       –      –    2020-04-03 3 IO $0.00 $0 D/D 0 445,404     -
   Gallagher Cam Director   –       •      –    2020-04-03 3 IO $0.00 $0 D/D 0 415,665     -
   Shabet Rose Sharon 10% Owner   –       –       •   2020-04-03 3 IO $0.00 $0 I/I 0 3,718,284     -
   Epperly Melissa B, Chief Financial OfficerOfficer   •       –      –    2020-04-03 3 IO $0.00 $0 D/D 0 130,135     -
   Sun Anthony Y President & CEOOfficer   •       •      –    2020-04-03 3 IO $0.00 $0 I/I 0 974,302     -
   Sun Anthony Y President & CEOOfficer   •       •      –    2020-04-03 3 IO $0.00 $0 D/D 0 1,842,288     -
   Johnson David Michael Director   –       •      –    2020-04-03 3 IO $0.00 $0 D/D 0 59,061     -

  237 Records found
  Previous  10    
  Page 10 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed